Enrofloxacin Market

Enrofloxacin Market - Size, Share, Outlook, and
Opportunity Analysis, 2019 – 2027
The global enrofloxacin market size is expected to witness potential gains in the future, and
register a significant CAGR over the forecast period (2019 – 2027).
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2742
Market Overview
Enrofloxacin (ENR) is a fluoroquinolone antibiotic and a veterinary antibacterial agent. It is sold
under the trade name Baytril by the Bayer Corporation. ENR is currently approved for
treatment of individual pets and domestic animals in the U.S. by the U.S. Food and Drug
Administration (FDA). ENR is effective against a several gram-positive and gram-negative
bacteria such as Pseudomonas aeruginosa, Klebsiella, and E.coli. It is used for the treatment of
infections of skin and soft tissue, urinary tract infections in dogs and cats, Chlamydophila felis
infections in cats, and ulcerative colitis caused by Escherichia coli in dogs. Significant growth in
the poultry sector is expected to have positive impact on the market growth of enrofloxacin
over the forecast period.
Market Dynamics
Increasing use of ENR in treatment of infections caused by both Gram-negative and Grampositive bacteria is expected to boost the market growth. ENR is administered to cattle by
subcutaneous injection and to pigs by intramuscular injection. It is administered orally to cattle,
pigs, turkey, and chickens, for the treatment of infections of the respiratory and alimentary
tract.
However, in rare instances, use of ENR in cats has been linked with retinal toxicity. The drug
cannot be used in pets that are allergic to it. ENR is also associated with some side effects such
as vomiting, diarrhea, and lack of appetite. Moreover, effective in September 2005, enrofloxacin
was withdrawn from use in the U.S. poultry farms. These factors are expected to hinder growth
of the enrofloxacin market over the forecast period.
Increasing trend of adopting pets is expected to offer lucrative opportunities for market players
to enhance their market share.
Report includes chapters which deeply display the following deliverable about industry :
• Enrofloxacin Market Research Objective and Assumption
• Enrofloxacin Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Enrofloxacin Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Enrofloxacin Market, By Regions
• Enrofloxacin Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Enrofloxacin Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Enrofloxacin Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Enrofloxacin Market Forecast including Production, Consumption, Import and Export Forecast
by Type, Applications and Region.
• Research Findings and Conclusion
Market Outlook
Asia Pacific is expected to hold dominant position in the enrofloxacin market over the forecast
period. Factors such as growing population and high demand for poultry meat are expected to
impact the market growth. Moreover, significant growth in the pet industry in China is also
expected to contribute to the market growth in Asia Pacific. Restrictions on the use of ENR in
the U.S. is expected to adversely affect growth of the market in North America.
Key Players
Some of the major players operating in the global enrofloxacin market include, Bayer
Corporation, KRKA d.d., Novo mesto, Pro Zoon, Chanelle Pharmaceuticals, VetMedic, and VM
Pharma.
Browse Complete Report For More Information @ http://bit.ly/2YkCiRS
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Enrofloxacin (ENR) is a fluoroquinolone antibiotic and a veterinary antibacterial agent. It is sold under the trade name Baytril by the Bayer Corporation.

Download Report